
Propanc Biopharma, Inc. (NASDAQ:PPCB) shares are trading higher Monday. The company recently priced a $4 million public offering and began trading on the Nasdaq Capital Market.
What To Know: The underwritten offering covers 1 million shares of common stock at $4.00 per share, expected to generate approximately $4 million in gross proceeds before expenses and underwriting discounts and commissions.